The two molecules, c-MET and HGF have an increased expression in various cancers such as non-small cell lung carcinoma (NSCLC), gastric, ovarian, pancreatic, thyroid, breast, head and neck, colon, and kidney carcinomas [45]. This evidence concerns the gene HGF and cancer.